Further analysis of ccRCC suggested that these mature plasma cells within the TLS are guided by CXCL12+ fibroblasts to migrate deeper into tumor foci while producing IgG and IgA antibodies and boosting anti-tumor effects [180]. The gene discussed is CD79A; the disease is neoplasm.